Anton Yuryev, PhD

Anton, author of over 50 scientific articles and four books in drug design and bioinformatics, has worked for 30+ years in life sciences. He co-founded Ariadne Genomics that developed Pathway Studio and MedScan NLP technology, acquired by Elsevier in 2011. He is focusing on pathway and network analysis using biomedical knowledgebases developing methods for personalized and precision medicine.